developing world HIV/AIDS

US regulators approve new two-drug combination pill for HIV

The US Food and Drug Administration (FDA) this week approved Dovato, a new single-tablet antiretroviral regimen containing the HIV integrase inhibitor dolutegravir (sold separately as Tivicay) and the nucleoside reverse transcriptase inhibitor lamivudine. Dovato, from...

read more

Monoclonal antibody may lead to long-term viral load reduction

An experimental monoclonal antibody called PGT121 led to viral suppression that lasted for up to six months in HIV-positive people who started with a low viral load, according to results from a small study presented at the Conference on Retroviruses and Opportunistic...

read more